cd 2019 has been researched along with tamibarotene in 1 studies
| Studies (cd 2019) | Trials (cd 2019) | Recent Studies (post-2010) (cd 2019) | Studies (tamibarotene) | Trials (tamibarotene) | Recent Studies (post-2010) (tamibarotene) |
|---|---|---|---|---|---|
| 12 | 0 | 2 | 198 | 10 | 105 |
| Protein | Taxonomy | cd 2019 (IC50) | tamibarotene (IC50) |
|---|---|---|---|
| Chain A, PROTEIN (CRABP-I) | Bos taurus (cattle) | 0.14 | |
| Chain A, PROTEIN (CRABP-II) | Homo sapiens (human) | 0.14 | |
| Chain A, PROTEIN (CRABP-II) | Homo sapiens (human) | 0.14 | |
| Retinoic acid receptor alpha | Homo sapiens (human) | 0.078 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, H; Iba, K; Ishii, S; Mori, M; Nuka, S; Sawada, N | 1 |
1 other study(ies) available for cd 2019 and tamibarotene
| Article | Year |
|---|---|
All-trans retinoic acid inhibits dexamethasone-induced ALP activity and mineralization in human osteoblastic cell line SV HFO.
Topics: Alkaline Phosphatase; Benzoates; Biomarkers; Calcification, Physiologic; Cell Line; Dexamethasone; Enzyme Inhibitors; Humans; Naphthalenes; Osteoblasts; Osteocalcin; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoids; Teratogens; Tetrahydronaphthalenes; Tretinoin | 1997 |